[
  {
    "ts": null,
    "headline": "Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS",
    "summary": "NEW YORK, December 05, 2024--Pfizer Inc. (NYSE: PFE) will highlight the latest advancements from its growing hematology and breast cancer portfolios at the American Society of Hematology (ASH) Annual Meeting & Exposition (December 7-10) and the San Antonio Breast Cancer Symposium (SABCS, December 10-13). Data from more than 100 company-sponsored, investigator-sponsored, and collaborative research abstracts, including 13 oral presentations and four poster spotlights, will be shared across the com",
    "url": "https://finnhub.io/api/news?id=d42daa5e04c5761108f8059cb46804b3fbcdf79f2091472d639eaaef0a4198de",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733436360,
      "headline": "Pfizer Showcases Scientific Leadership in Breast Cancer and Blood Disorders Across More than 100 Presentations at ASH and SABCS",
      "id": 131804593,
      "image": "https://media.zenfs.com/en/business-wire.com/d1a8754333bb60acdfa9e16ccf71088b",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NEW YORK, December 05, 2024--Pfizer Inc. (NYSE: PFE) will highlight the latest advancements from its growing hematology and breast cancer portfolios at the American Society of Hematology (ASH) Annual Meeting & Exposition (December 7-10) and the San Antonio Breast Cancer Symposium (SABCS, December 10-13). Data from more than 100 company-sponsored, investigator-sponsored, and collaborative research abstracts, including 13 oral presentations and four poster spotlights, will be shared across the com",
      "url": "https://finnhub.io/api/news?id=d42daa5e04c5761108f8059cb46804b3fbcdf79f2091472d639eaaef0a4198de"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=66ffe9109a94114dd9f8ba1eca397475ee7c0693e91eace7b861a9006b7338ad",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733416800,
      "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "id": 131876524,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=66ffe9109a94114dd9f8ba1eca397475ee7c0693e91eace7b861a9006b7338ad"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock Falls 8% in a Month: Should You Buy the Dip?",
    "summary": "Investors with a long-term horizon may consider buying PFE stock at its present attractive valuation.",
    "url": "https://finnhub.io/api/news?id=cd2616cae29bf7e696432e1af1a4912c684a9cacec2a9bd3386015e6bb27879c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733405400,
      "headline": "Pfizer Stock Falls 8% in a Month: Should You Buy the Dip?",
      "id": 131793410,
      "image": "https://media.zenfs.com/en/zacks.com/adffdba251acf14694302f71548fc8fb",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investors with a long-term horizon may consider buying PFE stock at its present attractive valuation.",
      "url": "https://finnhub.io/api/news?id=cd2616cae29bf7e696432e1af1a4912c684a9cacec2a9bd3386015e6bb27879c"
    }
  },
  {
    "ts": null,
    "headline": "FDA Accepts Roche's Columvi sBLA for Expanded Use in Lymphoma",
    "summary": "The FDA accepts RHHBY's sBLA seeking the label expansion of Columvi to include the treatment of second-line R/R DLBCL for review.",
    "url": "https://finnhub.io/api/news?id=363c4a092f1da6d60701f2fa979fd7eb14f328f418bf58ac90b835ee9b1f1d10",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733405040,
      "headline": "FDA Accepts Roche's Columvi sBLA for Expanded Use in Lymphoma",
      "id": 131791903,
      "image": "https://media.zenfs.com/en/zacks.com/d12eb3cde35a8fdb0f38466dd3f64a4d",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The FDA accepts RHHBY's sBLA seeking the label expansion of Columvi to include the treatment of second-line R/R DLBCL for review.",
      "url": "https://finnhub.io/api/news?id=363c4a092f1da6d60701f2fa979fd7eb14f328f418bf58ac90b835ee9b1f1d10"
    }
  },
  {
    "ts": null,
    "headline": "Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports",
    "summary": "U.S. President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer and Eli Lilly as well as industry lobbying group PhRMA on Wednesday night, Axios reported on Thursday. ...",
    "url": "https://finnhub.io/api/news?id=4394c31dbf7352d769b627a479cde02a6ae38c9d80e21b399f2901ed102891ff",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733403673,
      "headline": "Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports",
      "id": 131796390,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer and Eli Lilly as well as industry lobbying group PhRMA on Wednesday night, Axios reported on Thursday. ...",
      "url": "https://finnhub.io/api/news?id=4394c31dbf7352d769b627a479cde02a6ae38c9d80e21b399f2901ed102891ff"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer: Too Cheap To Ignore",
    "summary": "Pfizerâs 2024 guidance is upgraded with strong revenue growth. See why PFE stock offers an attractive dividend yield despite risks in the oncology space.",
    "url": "https://finnhub.io/api/news?id=3c7905efdf534a84e28b474a76125235970547ed3a86d753cc8ed1bea891d1e6",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733401909,
      "headline": "Pfizer: Too Cheap To Ignore",
      "id": 131795473,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440985/image_1292440985.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizerâs 2024 guidance is upgraded with strong revenue growth. See why PFE stock offers an attractive dividend yield despite risks in the oncology space.",
      "url": "https://finnhub.io/api/news?id=3c7905efdf534a84e28b474a76125235970547ed3a86d753cc8ed1bea891d1e6"
    }
  },
  {
    "ts": null,
    "headline": "Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?",
    "summary": "The company is still suffering from the significant drop in sales of its coronavirus products and the less-than-impressive financial results it has produced during the past two years.  Pfizer has, unquestionably, made progress.  Many new approvals and acquisitions have expanded its lineup and pipeline.",
    "url": "https://finnhub.io/api/news?id=4965ba80cae77a7b2416beda9ac2c44b7ddcc78d5e5b83a22d0c808594c1e069",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733400900,
      "headline": "Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?",
      "id": 131791972,
      "image": "https://g.foolcdn.com/editorial/images/799291/scientist-altering-dna-genome-project.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The company is still suffering from the significant drop in sales of its coronavirus products and the less-than-impressive financial results it has produced during the past two years.  Pfizer has, unquestionably, made progress.  Many new approvals and acquisitions have expanded its lineup and pipeline.",
      "url": "https://finnhub.io/api/news?id=4965ba80cae77a7b2416beda9ac2c44b7ddcc78d5e5b83a22d0c808594c1e069"
    }
  },
  {
    "ts": null,
    "headline": "Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks",
    "summary": "Top-ranked stocks Urban Outfitters, Maplebear, Pfizer and Alcoa are likely to beat on the bottom line in their upcoming releases.",
    "url": "https://finnhub.io/api/news?id=abde32d59d438af358df9a7f8aaed420e340633cd8e70641aff982fb785cea0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733395440,
      "headline": "Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks",
      "id": 131793415,
      "image": "https://media.zenfs.com/en/zacks.com/3136c22cf05e163ab2bb94a2755707e9",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Top-ranked stocks Urban Outfitters, Maplebear, Pfizer and Alcoa are likely to beat on the bottom line in their upcoming releases.",
      "url": "https://finnhub.io/api/news?id=abde32d59d438af358df9a7f8aaed420e340633cd8e70641aff982fb785cea0e"
    }
  },
  {
    "ts": null,
    "headline": "Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now.",
    "summary": "Investing $5,000 can be a good amount to put into a growth stock because it can lead to significant long-term gains.  Three stocks that I think could be good growth stocks if you have $5,000 to invest today are Pfizer (NYSE: PFE), ExxonMobil (NYSE: XOM), and Carnival Corp. (NYSE: CCL).  Here's why these can be ideal options for growth investors, particularly if you're looking for good value buys, as well.",
    "url": "https://finnhub.io/api/news?id=389524d887eea722c9f188c09381ce737df2f66c42c385ab27aa8fc65be8ff5e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733392500,
      "headline": "Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now.",
      "id": 131792536,
      "image": "https://g.foolcdn.com/editorial/images/799423/two-people-in-a-business-meeting.jpg",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Investing $5,000 can be a good amount to put into a growth stock because it can lead to significant long-term gains.  Three stocks that I think could be good growth stocks if you have $5,000 to invest today are Pfizer (NYSE: PFE), ExxonMobil (NYSE: XOM), and Carnival Corp. (NYSE: CCL).  Here's why these can be ideal options for growth investors, particularly if you're looking for good value buys, as well.",
      "url": "https://finnhub.io/api/news?id=389524d887eea722c9f188c09381ce737df2f66c42c385ab27aa8fc65be8ff5e"
    }
  },
  {
    "ts": null,
    "headline": "11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs",
    "summary": "The Euphoria index is at record highs, indicating bullish sentiment. Check out a selection of dividend stocks that could present safety and income.",
    "url": "https://finnhub.io/api/news?id=cec27ac84161aa0524de0e51036f543f1148e1b60017ecdb66d5855a581a4033",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733382000,
      "headline": "11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs",
      "id": 131790774,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/76133201/image_76133201.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "The Euphoria index is at record highs, indicating bullish sentiment. Check out a selection of dividend stocks that could present safety and income.",
      "url": "https://finnhub.io/api/news?id=cec27ac84161aa0524de0e51036f543f1148e1b60017ecdb66d5855a581a4033"
    }
  },
  {
    "ts": null,
    "headline": "Haleon says Pfizer representative steps down from board",
    "summary": "Haleon PLC - Weybridge, Surrey-based consumer healthcare products - Says Pfizer Inc representative and Non-Executive Director, David Denton, stepped down from Haleon's board on Wednesday following the...",
    "url": "https://finnhub.io/api/news?id=a77d48c9d5bac55055191cb0590e08ab7b66b1d1780d10b2220fbced2572ec9f",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733378180,
      "headline": "Haleon says Pfizer representative steps down from board",
      "id": 131790319,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Haleon PLC - Weybridge, Surrey-based consumer healthcare products - Says Pfizer Inc representative and Non-Executive Director, David Denton, stepped down from Haleon's board on Wednesday following the...",
      "url": "https://finnhub.io/api/news?id=a77d48c9d5bac55055191cb0590e08ab7b66b1d1780d10b2220fbced2572ec9f"
    }
  },
  {
    "ts": null,
    "headline": "Health equity and women's health emerge as key themes of the inaugural International Health Ministerial Summit",
    "summary": "The inaugural International Health Ministerial Summit, organised by Informa Markets , began with a series of dynamic panel discussions featuring influential delegates showcasing collaborative...",
    "url": "https://finnhub.io/api/news?id=d68bb8eeab4feb9feb3b7a6d301f9d79dcf1ffd1afcb60dd59e0b7b2e872e389",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733372105,
      "headline": "Health equity and women's health emerge as key themes of the inaugural International Health Ministerial Summit",
      "id": 131786079,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "The inaugural International Health Ministerial Summit, organised by Informa Markets , began with a series of dynamic panel discussions featuring influential delegates showcasing collaborative...",
      "url": "https://finnhub.io/api/news?id=d68bb8eeab4feb9feb3b7a6d301f9d79dcf1ffd1afcb60dd59e0b7b2e872e389"
    }
  },
  {
    "ts": null,
    "headline": "Health equity and women’s health emerge as key themes of the inaugural International Health Ministerial SummitThe exclusive by-invitation only Summit, themed Strengthening Health Systems for a Better Tomorrow, takes place from 4 to 5 December 2024 at the Marriott in Kigali",
    "summary": "The inaugural International Health Ministerial Summit, organised by Informa Markets , began with a series of dynamic panel discussions featuring influential delegates showcasing collaborative...",
    "url": "https://finnhub.io/api/news?id=66ea12dc0b331331194c9350752765c5a49b7a58e02a4a5c15c378fe055a1ba1",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733371087,
      "headline": "Health equity and women’s health emerge as key themes of the inaugural International Health Ministerial SummitThe exclusive by-invitation only Summit, themed Strengthening Health Systems for a Better Tomorrow, takes place from 4 to 5 December 2024 at the Marriott in Kigali",
      "id": 131784857,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "The inaugural International Health Ministerial Summit, organised by Informa Markets , began with a series of dynamic panel discussions featuring influential delegates showcasing collaborative...",
      "url": "https://finnhub.io/api/news?id=66ea12dc0b331331194c9350752765c5a49b7a58e02a4a5c15c378fe055a1ba1"
    }
  }
]